Market Cap 100.26B
Revenue (ttm) 403.43B
Net Income (ttm) 4.76B
EPS (ttm) N/A
PE Ratio 21.29
Forward PE 19.46
Profit Margin 1.18%
Debt to Equity Ratio -3.83
Volume 618,700
Avg Vol 1,053,512
Day's Range N/A - N/A
Shares Out 116.59M
Stochastic %K 40%
Beta 0.30
Analysts Strong Sell
Price Target $979.75

Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions;...

Industry: Medical Distribution
Sector: Healthcare
Phone: 972 446 4800
Address:
6555 State Highway 161, Irving, United States
cynicaloptimist
cynicaloptimist Aug. 18 at 7:59 PM
$LLY $MCK foundation to weather momentum storms. $XLV
0 · Reply
DidYouReadThis
DidYouReadThis Aug. 14 at 1:49 AM
For any #microcap #pharma #stock with a #new #FDAapproval, is there an #average #number of #quarters to #switch from -#negative to #positive #EPS? $BRK.B $MCK $LLY $MRK
0 · Reply
DanfromBAMA
DanfromBAMA Aug. 11 at 11:48 PM
$MCK upward trend. But I am dumb af tho
1 · Reply
JamesTaulman
JamesTaulman Aug. 10 at 2:39 PM
MON 8/10: $MCK – BUYING (1/3) @ $892.55 9:58 AM – Initiating a 1/3 position in this Medical-Distribution leader as shares trade higher from the 10 DMA on what is currently running at approximately twice normal daily trading volume. The combination of support at the 10 DMA, advancing price, and sharply increased volume represents the type of bullish technical action I consider a BUY SIGNAL. James’ Trader’s Tip: Volume Adds Conviction to a Move • A stock advancing from the 10 DMA shows that this key technical level is acting as support. • When that move occurs on sharply increased volume, it signals stronger-than-normal buying demand. • Price strength combined with expanding volume provides greater confirmation than price movement alone. https://buyingbreakouts.com/mon-8-10-mck-buying-1-3-892-55/
0 · Reply
MaverikIT
MaverikIT Aug. 10 at 1:58 PM
@Jblack500 @cynicaloptimist @BustaCapital @IsabellaDC @WAJeff @No_Face_character $LLY $MCK cont to be $AXSM awesome$
0 · Reply
ryan2022
ryan2022 Aug. 6 at 8:58 PM
$MCK already came within a dollar of $1,000 earlier this year. I’m looking forward to another run to 4 digits.
0 · Reply
PanicSeller8
PanicSeller8 Aug. 6 at 4:33 PM
$MCK Added some here. Surprised to see it trade so poorly today.
0 · Reply
profit_guru
profit_guru Aug. 6 at 1:13 PM
$MCK - solid earnings beat and top line is increasing in high margin categories like oncology and specialty..,near term 1000…imo
0 · Reply
ryan2022
ryan2022 Aug. 6 at 12:57 AM
$MCK earnings beat, guidance raised, dividend increase, price target raised to 1k. Thanks Pop!
0 · Reply
EarningsInsider
EarningsInsider Aug. 5 at 9:46 PM
https://www.marketbeat.com/earnings/reports/2026-8-5-mckesson-co-stock/ $MCK McKesson Earnings Transcript
0 · Reply
Latest News on MCK
McKesson price target raised to $1,000 from $925 at Barclays

2026-08-19T09:30:10.000Z - 2 hours ago

McKesson price target raised to $1,000 from $925 at Barclays


McKesson initiated with a Sector Perform at RBC Capital

2026-08-19T09:10:23.000Z - 3 hours ago

McKesson initiated with a Sector Perform at RBC Capital


McKesson price target raised to $1,015 from $955 at Baird

2026-08-06T13:26:16.000Z - 12 days ago

McKesson price target raised to $1,015 from $955 at Baird


McKesson price target raised to $1,006 from $989 at TD Cowen

2026-08-06T12:51:14.000Z - 12 days ago

McKesson price target raised to $1,006 from $989 at TD Cowen


McKesson price target raised to $1,080 from $1,050 at UBS

2026-08-06T12:43:27.000Z - 12 days ago

McKesson price target raised to $1,080 from $1,050 at UBS


McKesson price target raised to $905 from $885 at Mizuho

2026-08-06T11:23:04.000Z - 13 days ago

McKesson price target raised to $905 from $885 at Mizuho


McKesson Earnings Call Transcript: Q1 2027

Aug 5, 2026, 4:30 PM EDT - 13 days ago

McKesson Earnings Call Transcript: Q1 2027


McKesson Earnings release: Q1 2027

Aug 5, 2026, 4:30 PM EDT - 13 days ago

McKesson Earnings release: Q1 2027


McKesson Slides: Q1 2027

Aug 5, 2026, 4:30 PM EDT - 13 days ago

McKesson Slides: Q1 2027


McKesson Quarterly report: Q1 2027

Aug 5, 2026, 4:30 PM EDT - 13 days ago

McKesson Quarterly report: Q1 2027


McKesson reports Q1 adjusted EPS $9.93, consensus $9.54

2026-08-05T20:17:36.000Z - 13 days ago

McKesson reports Q1 adjusted EPS $9.93, consensus $9.54


McKesson price target raised to $1,000 from $945 at Citi

2026-07-24T10:46:10.000Z - 26 days ago

McKesson price target raised to $1,000 from $945 at Citi


McKesson price target raised to $925 from $900 at BofA

2026-07-21T12:50:33.000Z - 4 weeks ago

McKesson price target raised to $925 from $900 at BofA


McKesson price target lowered to $989 from $1,012 at TD Cowen

2026-07-21T12:46:49.000Z - 4 weeks ago

McKesson price target lowered to $989 from $1,012 at TD Cowen


McKesson Proxy statement: Proxy filing

Jun 30, 2026, 8:00 AM EDT - 7 weeks ago

McKesson Proxy statement: Proxy filing


McKesson Proxy statement: Proxy filing

Jun 12, 2026, 8:00 AM EDT - 2 months ago

McKesson Proxy statement: Proxy filing


McKesson Proxy statement: Proxy filing

Jun 12, 2026, 8:00 AM EDT - 2 months ago

McKesson Proxy statement: Proxy filing


McKesson price target lowered to $925 from $1,050 at Barclays

2026-06-10T09:15:35.000Z - 2 months ago

McKesson price target lowered to $925 from $1,050 at Barclays


McKesson Earnings Call Transcript: Q4 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

McKesson Earnings Call Transcript: Q4 2026


McKesson Earnings release: Q4 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

McKesson Earnings release: Q4 2026


McKesson Slides: Q4 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

McKesson Slides: Q4 2026


McKesson Annual report: Q4 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

McKesson Annual report: Q4 2026


McKesson Annual report: Q4 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

McKesson Annual report: Q4 2026


McKesson Corporation Declares Quarterly Dividend

Apr 22, 2026, 8:00 AM EDT - 4 months ago

McKesson Corporation Declares Quarterly Dividend


Is McKesson Stock Still A High-Conviction Compounder?

Apr 21, 2026, 12:26 PM EDT - 4 months ago

Is McKesson Stock Still A High-Conviction Compounder?


McKesson to Sell Stake of Medical-Surgical Unit to Apollo

Apr 20, 2026, 8:58 AM EDT - 4 months ago

McKesson to Sell Stake of Medical-Surgical Unit to Apollo

APO


McKesson Transcript: Leerink Global Healthcare Conference 2026

Mar 11, 2026, 10:00 AM EDT - 5 months ago

McKesson Transcript: Leerink Global Healthcare Conference 2026


McKesson Announces Planned CFO Transition

Mar 5, 2026, 8:10 AM EST - 5 months ago

McKesson Announces Planned CFO Transition


See How Institutional Inflows Make McKesson Fly

Feb 25, 2026, 8:26 AM EST - 6 months ago

See How Institutional Inflows Make McKesson Fly


How McKesson Stock Surged 17% In A Day

Feb 6, 2026, 11:25 AM EST - 6 months ago

How McKesson Stock Surged 17% In A Day


McKesson boosts 2026 profit forecast amid specialty drug growth

Feb 4, 2026, 7:01 PM EST - 6 months ago

McKesson boosts 2026 profit forecast amid specialty drug growth


McKesson Earnings Call Transcript: Q3 2026

Feb 4, 2026, 4:30 PM EST - 6 months ago

McKesson Earnings Call Transcript: Q3 2026


McKesson Quarterly report: Q3 2026

Feb 4, 2026, 4:30 PM EST - 6 months ago

McKesson Quarterly report: Q3 2026


McKesson Earnings release: Q3 2026

Feb 4, 2026, 4:30 PM EST - 6 months ago

McKesson Earnings release: Q3 2026


McKesson Slides: Q3 2026

Feb 4, 2026, 4:30 PM EST - 6 months ago

McKesson Slides: Q3 2026


McKesson Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 12:45 PM EST - 7 months ago

McKesson Transcript: 44th Annual J.P. Morgan Healthcare Conference


McKesson Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 12:45 PM EST - 7 months ago

McKesson Slides: 44th Annual J.P. Morgan Healthcare Conference


Final Trades: Lockheed Martin, QXO and McKesson Corporation

Jan 5, 2026, 1:46 PM EST - 8 months ago

Final Trades: Lockheed Martin, QXO and McKesson Corporation

LMT QXO


McKesson Transcript: UBS Global Healthcare Conference 2025

Nov 10, 2025, 9:30 AM EST - 10 months ago

McKesson Transcript: UBS Global Healthcare Conference 2025


McKesson Earnings Call Transcript: Q2 2026

Nov 5, 2025, 4:30 PM EST - 10 months ago

McKesson Earnings Call Transcript: Q2 2026


McKesson Quarterly report: Q2 2026

Nov 5, 2025, 4:30 PM EST - 10 months ago

McKesson Quarterly report: Q2 2026


McKesson Earnings release: Q2 2026

Nov 5, 2025, 4:30 PM EST - 10 months ago

McKesson Earnings release: Q2 2026


McKesson Slides: Q2 2026

Nov 5, 2025, 4:30 PM EST - 10 months ago

McKesson Slides: Q2 2026


The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.

Oct 14, 2025, 12:47 PM EDT - 11 months ago

The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.

COR WFC


How to trade the health care break out

Oct 6, 2025, 2:24 PM EDT - 11 months ago

How to trade the health care break out

MRK UNH VEEV XBI XLV


See How McKesson Shares Rise with Money Flows

Oct 1, 2025, 7:28 AM EDT - 11 months ago

See How McKesson Shares Rise with Money Flows


McKesson Transcript: Investor Day 2025

Sep 23, 2025, 9:30 AM EDT - 11 months ago

McKesson Transcript: Investor Day 2025


McKesson Slides: FY 2025

Sep 23, 2025, 9:30 AM EDT - 11 months ago

McKesson Slides: FY 2025


McKesson Announces New Organizational Structure

Sep 18, 2025, 8:00 AM EDT - 11 months ago

McKesson Announces New Organizational Structure


McKesson Earnings Call Transcript: Q1 2026

Aug 6, 2025, 4:30 PM EDT - 1 year ago

McKesson Earnings Call Transcript: Q1 2026


McKesson Earnings release: Q1 2026

Aug 6, 2025, 4:30 PM EDT - 1 year ago

McKesson Earnings release: Q1 2026


McKesson Quarterly report: Q1 2026

Aug 6, 2025, 4:30 PM EDT - 1 year ago

McKesson Quarterly report: Q1 2026


McKesson Slides: Q1 2026

Aug 6, 2025, 4:30 PM EDT - 1 year ago

McKesson Slides: Q1 2026


McKesson Proxy statement: Proxy Filing

Jul 2, 2025, 8:00 AM EDT - 1 year ago

McKesson Proxy statement: Proxy Filing


McKesson Proxy statement: Proxy Filing

Jun 20, 2025, 8:00 AM EDT - 1 year ago

McKesson Proxy statement: Proxy Filing


McKesson Proxy statement: Proxy Filing

Jun 20, 2025, 8:00 AM EDT - 1 year ago

McKesson Proxy statement: Proxy Filing


McKesson to Host Investor Day on September 23, 2025

Jun 11, 2025, 8:00 AM EDT - 1 year ago

McKesson to Host Investor Day on September 23, 2025


McKesson Corporation Completes Acquisition of Core Ventures

Jun 3, 2025, 8:00 AM EDT - 1 year ago

McKesson Corporation Completes Acquisition of Core Ventures


McKesson To Spin-Off Its Medical-Surgical Solutions Business

May 15, 2025, 2:05 PM EDT - 1 year ago

McKesson To Spin-Off Its Medical-Surgical Solutions Business


McKesson Transcript: Bank of America 2025 Healthcare Conference

May 13, 2025, 11:00 AM EDT - 1 year ago

McKesson Transcript: Bank of America 2025 Healthcare Conference


cynicaloptimist
cynicaloptimist Aug. 18 at 7:59 PM
$LLY $MCK foundation to weather momentum storms. $XLV
0 · Reply
DidYouReadThis
DidYouReadThis Aug. 14 at 1:49 AM
For any #microcap #pharma #stock with a #new #FDAapproval, is there an #average #number of #quarters to #switch from -#negative to #positive #EPS? $BRK.B $MCK $LLY $MRK
0 · Reply
DanfromBAMA
DanfromBAMA Aug. 11 at 11:48 PM
$MCK upward trend. But I am dumb af tho
1 · Reply
JamesTaulman
JamesTaulman Aug. 10 at 2:39 PM
MON 8/10: $MCK – BUYING (1/3) @ $892.55 9:58 AM – Initiating a 1/3 position in this Medical-Distribution leader as shares trade higher from the 10 DMA on what is currently running at approximately twice normal daily trading volume. The combination of support at the 10 DMA, advancing price, and sharply increased volume represents the type of bullish technical action I consider a BUY SIGNAL. James’ Trader’s Tip: Volume Adds Conviction to a Move • A stock advancing from the 10 DMA shows that this key technical level is acting as support. • When that move occurs on sharply increased volume, it signals stronger-than-normal buying demand. • Price strength combined with expanding volume provides greater confirmation than price movement alone. https://buyingbreakouts.com/mon-8-10-mck-buying-1-3-892-55/
0 · Reply
MaverikIT
MaverikIT Aug. 10 at 1:58 PM
@Jblack500 @cynicaloptimist @BustaCapital @IsabellaDC @WAJeff @No_Face_character $LLY $MCK cont to be $AXSM awesome$
0 · Reply
ryan2022
ryan2022 Aug. 6 at 8:58 PM
$MCK already came within a dollar of $1,000 earlier this year. I’m looking forward to another run to 4 digits.
0 · Reply
PanicSeller8
PanicSeller8 Aug. 6 at 4:33 PM
$MCK Added some here. Surprised to see it trade so poorly today.
0 · Reply
profit_guru
profit_guru Aug. 6 at 1:13 PM
$MCK - solid earnings beat and top line is increasing in high margin categories like oncology and specialty..,near term 1000…imo
0 · Reply
ryan2022
ryan2022 Aug. 6 at 12:57 AM
$MCK earnings beat, guidance raised, dividend increase, price target raised to 1k. Thanks Pop!
0 · Reply
EarningsInsider
EarningsInsider Aug. 5 at 9:46 PM
https://www.marketbeat.com/earnings/reports/2026-8-5-mckesson-co-stock/ $MCK McKesson Earnings Transcript
0 · Reply
profit_guru
profit_guru Aug. 5 at 9:12 PM
$CAH - might rally above 350 on strong $MCK earnings and guidance…near term 260…imo
0 · Reply
TheGoatBull
TheGoatBull Aug. 5 at 9:03 PM
$MCK 1k? 🤪
0 · Reply
cynicaloptimist
cynicaloptimist Aug. 5 at 8:38 PM
$MCK 💪
0 · Reply
profit_guru
profit_guru Aug. 5 at 8:16 PM
$MCK - solid beat and raise quarter…way oversold compared to peers ….might rally above 950 tomorrow….expect multiple price target raises tomorrow
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 5 at 8:13 PM
$MCK Q1 '27 Earnings Results & Recap • Reported GAAP EPS of $5.17 down -17.68% YoY • Reported revenue of $105.38B up 7.72% YoY • McKesson Corporation raised its fiscal 2027 Adjusted Earnings per Diluted Share guidance range to $44.20 to $45.00, indicating 13% to 15% growth compared to the prior year for McKesson Corporation.
0 · Reply
Estimize
Estimize Aug. 5 at 8:03 PM
Wall St is expecting 10.75 EPS for $MCK Q2 [Reporting 11/03 AMC] http://www.estimize.com/intro/mck?chart=historical&metric_name=eps&utm_con
0 · Reply
27R
27R Aug. 5 at 3:28 PM
$MCK reports after the close today; recent post-earnings paths look more mixed than quiet, so tonight’s reaction may take a bit to settle.
0 · Reply
Estimize
Estimize Aug. 5 at 3:01 PM
$MCK reports after the close, Estimize Consensus +0.25 EPS and +1.11B Revs compared to WS http://www.estimize.com/mck/fq1-2027?utm_content=
0 · Reply
StellaAtchison1037
StellaAtchison1037 Aug. 5 at 6:41 AM
$ING $USB $SPOT $MCK $KKR ING benefits from European banking, U.S. Bancorp provides reliable financial services, Spotify continues expanding premium subscriptions, McKesson leads healthcare distribution, and KKR grows alternative asset management.
0 · Reply
TRoptionTRADER
TRoptionTRADER Aug. 4 at 8:28 AM
$MCK u should wait under $800
0 · Reply
cynicaloptimist
cynicaloptimist Aug. 1 at 2:24 AM
$MCK adding at 835 for the long haul.
0 · Reply
OldManGrumble
OldManGrumble Jul. 31 at 1:38 AM
$MCK 0.03 beta, allegedly
0 · Reply